Free Trial
NASDAQ:HEPA

Hepion Pharmaceuticals (HEPA) Stock Price, News & Analysis

Hepion Pharmaceuticals logo
$0.05 0.00 (-1.67%)
As of 02:37 PM Eastern

About Hepion Pharmaceuticals Stock (NASDAQ:HEPA)

Advanced

Key Stats

Today's Range
$0.05
$0.06
50-Day Range
$0.04
$0.07
52-Week Range
$0.03
$0.10
Volume
20,128 shs
Average Volume
17,495 shs
Market Capitalization
$607.20 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive HEPA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Hepion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

HEPA Stock News Headlines

Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.tc pixel
HEPA Hepion Pharmaceuticals, Inc.C
See More Headlines

HEPA Stock Analysis - Frequently Asked Questions

Hepion Pharmaceuticals' stock was trading at $0.06 on January 1st, 2026. Since then, HEPA stock has decreased by 11.5% and is now trading at $0.0531.

Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) released its quarterly earnings data on Sunday, November, 15th. The company reported ($690.00) EPS for the quarter, missing the consensus estimate of ($510.00) by $180.00.

Hepion Pharmaceuticals shares reverse split before market open on Tuesday, March 18th 2025.The 1-50 reverse split was announced on Friday, March 14th 2025. The number of shares owned by shareholders was adjusted after the closing bell on Monday, March 17th 2025. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Shares of HEPA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Hepion Pharmaceuticals investors own include VBI Vaccines (VBIV), Sorrento Therapeutics (SRNE), FuelCell Energy (FCEL), NVIDIA (NVDA), Tonix Pharmaceuticals (TNXP), Advanced Micro Devices (AMD) and Meta Platforms (META).

Company Calendar

Last Earnings
11/15/2020
Today
5/05/2026
Next Earnings (Estimated)
5/12/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:HEPA
CIK
1583771
Employees
20
Year Founded
2013

Profitability

EPS (Trailing Twelve Months)
($72.15)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$48.93 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-812.56%
Return on Assets
-207.31%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.30
Quick Ratio
1.30

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.29 per share
Price / Book
0.04

Miscellaneous

Outstanding Shares
11,435,000
Free Float
6,631,000
Market Cap
$607.20 thousand
Optionable
No Data
Beta
1.52

Social Links

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:HEPA) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners